-+ 0.00%
-+ 0.00%
-+ 0.00%

Jones Trading Maintains Buy on Enliven Therapeutics, Raises Price Target to $70

Benzinga·06/29/2026 15:34:48
Listen to the news
Jones Trading analyst Boris Peaker maintains Enliven Therapeutics (NASDAQ:ELVN) with a Buy and raises the price target from $45 to $70.